OXFORD, United Kingdom and MADISON, N.J., Aug. 24, 2025 (GLOBE NEWSWIRE) -- Terumo Corporation (TSE: 4543, "Terumo") today announced that Terumo has entered into a definitive agreement dated August 23 ...
OXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, successfully completed a $142 million primary and secondary equity ...
British Growth Fund (BGF), a UK- and Ireland-based growth capital investor, has successfully exited Oxford University spinout OrganOx, a medtech company that develops a liver preservation device, in a ...
OrganOx enters next phase of growth for continued global expansion and access to life-saving technology OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly ...
BGF first invested in OrganOx in 2019 The deal has driven a 10x money multiple exit on BGF’s initial investment OrganOx was founded out of the University of Oxford BGF has exited its investment in ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--eGenesis, a biotechnology company developing human-compatible organs and cells for the treatment of organ failure, and OrganOx, a medical device company with a focus ...
OrganOx's metra has been used not just for human donor tissue, but also in genetically altered xenotransplants derived from pigs. The company and eGenesis have agreed to construct an extracorporeal ...
OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results